Premium
Reversible black tongue: A little known side effect of imipenem/cilastatin and evidence for novel mode of action
Author(s) -
Zhao Shujuan,
Fan Lei,
Feng Jing,
Ma Peizhi
Publication year - 2020
Publication title -
journal of clinical pharmacy and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.622
H-Index - 73
eISSN - 1365-2710
pISSN - 0269-4727
DOI - 10.1111/jcpt.13066
Subject(s) - tongue , cilastatin , imipenem , medicine , limiting , imipenem/cilastatin , ingestion , side effect (computer science) , anesthesia , antibiotics , surgery , pathology , biology , microbiology and biotechnology , mechanical engineering , antibiotic resistance , computer science , programming language , engineering
What is known and objective Black tongue syndrome (BT) is a rare and self‐limiting disorder which can result from physiological and metabolic condition and ingestion of toxic substances. Medications are the most common cause of BT. Case summary A 39‐year‐old male patient presented with BT after the initiation of imipenem/cilastatin. Within one week of cessation of these drugs, the patient's tongue returned to a normal colour. What is new and conclusion This is the first case of BT induced by imipenem/cilastatin. Withdrawal of the combination is likely to reverse the condition.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom